LiDCO Group Plc

("LiDCO" or the "Company")

LiDCO, with technology partners Intel and Advantech,

provides cutting edge medical products

LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, is pleased to announce that it has been featured in a case study from  Intel, world leader in silicon chip innovation, showcasing the LiDCOrapid Monitor.

Medical device manufacturers are under increasing pressure to provide hospitals with effective innovative products that achieve cost savings. The LiDCOrapid monitor achieves this by utilising Intel's innovative processing chips within terminals provided by Advantech, a leading provider of panel-based PCs to the healthcare market. These specialised monitors are fully compliant with all medical related technology standards, and lead the way in terms of display, performance and power consumption.  Using the combined expertises of both Intel and Advantech LiDCO's time to market has been dramatically reduced through being able to concentrate solely on optimising its core signal processing and unique monitoring software.

The LiDCOrapid Monitor provides physicians with vital information on the patient's fluid and cardiovascular status during surgery or while in intensive care. The LiDCOrapid Monitor has been chosen as the sole monitoring system to be used in OPTIMISE, a government-supported multi-centre trial in the UK, which aims to improve surgical outcomes by optimising patient's cardiovascular management. This trial is believed to be the largest of its type in the world to date and is therefore a significant validation of this novel technology.

Dr Terry O'Brien, CEO of LiDCO, commented:  "I am delighted that Intel has recognised LiDCO as an innovative and leading technology developer in the medical sector. We place a high emphasis on performance and quality; our ongoing relationship with Intel and Advantech allow us to deliver cutting edge technology cost effectively.  To be acknowledged in this case study for our innovation and having the product of that collaboration, the LiDCOrapid, chosen as the sole technology for the OPTIMISE study is a great honour for us."

The case study is now live on Intel's website and the full document can be downloaded here: http://download.intel.com/design/embedded/medical/323210.pdf.

- ENDS -

For more information please contact:

Media enquiries

About LiDCO Group Plc

LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus is a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

* LiDCOrapid: our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care. The monitor features many clinical benefits. These enable acute-care physicians to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being during and after surgery. These benefits are:

    Early and rapid warning of change

    Clear indication of therapeutic route: fluid or drug

    Quantification of hemodynamic response, particularly stroke volume

    Permits more effective delivery of fluids - the right amount at the right time

    Advanced hemodynamic care has been shown to contribute to: - Reduced morbidity and complications - Reduced length of stay - Reduced overall cost of care

* LiDCO single-patient-use disposables used in conjunction with the LiDCOplus and LiDCOrapid Monitors.

* LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus.

LiDCO Distribution Network:

The Company sells direct to hospitals in the UK, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors